Stereotaxis Ord Financials
Stereotaxis Ord (STXS) reported $32.4M in revenue for fiscal year 2025, up 20.3% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
External financing is still carrying an asset-light but cash-consuming business whose revenue recovery has not repaired margins.
In FY2025, operating cash flow of-$13.7M was funded almost one-for-one by financing inflow of$14.8M , so the better liquidity than FY2024 reflects outside capital rather than the business turning cash-generative. That matters because revenue rebounded while gross margin still slipped to52.7% from54.2% , meaning added sales carried weaker unit economics instead of easing the burn.
Free cash flow of
FY2025 gross profit of
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Stereotaxis Ord's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Stereotaxis Ord, and counted as zero in the overall score.
Stereotaxis Ord scores -13.60, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($142.3M) relative to total liabilities ($33.5M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Stereotaxis Ord passes 4 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, all 1 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Stereotaxis Ord reported a net loss of $21.6M while operations used $13.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Stereotaxis Ord reported an operating loss of $22.1M against $500K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Stereotaxis Ord generated $32.4M in revenue in fiscal year 2025. This represents an increase of 20.3% from the prior year.
Stereotaxis Ord's EBITDA was -$20.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 13.5% from the prior year.
Stereotaxis Ord reported -$21.6M in net income in fiscal year 2025. This represents an increase of 10.0% from the prior year.
Stereotaxis Ord earned -$0.25 per diluted share (EPS) in fiscal year 2025. This represents an increase of 16.7% from the prior year.
Cash & Balance Sheet
Stereotaxis Ord recorded an outflow of $13.8M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents a decrease of 61.5% from the prior year.
Stereotaxis Ord held $13.4M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Margins & Returns
Stereotaxis Ord's gross margin was 52.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 1.5 percentage points from the prior year.
Stereotaxis Ord's operating margin was -68.3% in fiscal year 2025, reflecting core business profitability. This is up 23.6 percentage points from the prior year.
Stereotaxis Ord's net profit margin was -66.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 22.5 percentage points from the prior year.
Stereotaxis Ord's ROE was -160.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 234.9 percentage points from the prior year.
Capital Allocation
Stereotaxis Ord invested $9.4M in research and development in fiscal year 2025. This represents a decrease of 3.9% from the prior year.
Stereotaxis Ord invested $93K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 173.5% from the prior year.
Not reported for fiscal year 2025.
STXS Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $30.1M | $32.4M+20.3% | $26.9M+0.5% | $26.8M-4.9% | $28.1M-19.6% | $35.0M+31.5% | $26.6M-7.9% | $28.9M-1.5% | $29.3M-5.8% | $31.1M-3.2% | $32.2M-14.6% | $37.7M+7.6% | $35.0M-7.9% | $38.0M-18.3% | $46.6M+10.9% | $42.0M |
| Cost of Revenue | $13.4M | $15.3M+24.2% | $12.3M+3.5% | $11.9M+23.1% | $9.7M-17.9% | $11.8M+53.8% | $7.7M+24.9% | $6.1M+7.3% | $5.7M-46.8% | $10.8M+42.8% | $7.5M-27.9% | $10.4M+26.9% | $8.2M-25.3% | $11.0M-25.6% | $14.8M+18.3% | $12.5M |
| Gross Profit | $16.7M | $17.1M+17.0% | $14.6M-1.8% | $14.9M-19.5% | $18.5M-20.5% | $23.2M+22.5% | $19.0M-16.7% | $22.8M-3.7% | $23.6M+15.9% | $20.4M-17.2% | $24.6M-9.6% | $27.2M+1.7% | $26.8M-0.9% | $27.0M-15.0% | $31.8M+7.8% | $29.5M |
| R&D Expenses | $10.0M | $9.4M-3.9% | $9.8M-5.0% | $10.3M-2.7% | $10.6M+3.5% | $10.2M+25.3% | $8.1M-9.8% | $9.0M+9.8% | $8.2M+22.6% | $6.7M+22.2% | $5.5M-12.2% | $6.3M+21.2% | $5.2M-9.1% | $5.7M-32.5% | $8.4M-34.8% | $12.9M |
| SG&A Expenses | $18.2M | $17.8M+3.8% | $17.2M+22.4% | $14.1M-2.2% | $14.4M+2.8% | $14.0M+119.6% | $6.4M+9.0% | $5.8M+19.1% | $4.9M-18.0% | $6.0M-42.2% | $10.3M-1.9% | $10.5M-11.0% | $11.8M-9.3% | $13.1M-2.5% | $13.4M-20.8% | $16.9M |
| Operating Income | -$22.8M | -$22.1M+10.6% | -$24.7M-13.3% | -$21.8M-16.3% | -$18.8M-45.7% | -$12.9M-92.0% | -$6.7M-39.1% | -$4.8M-96.5% | -$2.5M+58.5% | -$5.9M+7.9% | -$6.4M-18.8% | -$5.4M-0.5% | -$5.4M+39.1% | -$8.8M+16.8% | -$10.6M+66.7% | -$31.9M |
| Interest Expense | $467K | $500K-28.0% | $694K-36.7% | $1.1M+126.4% | $484K+4500.0% | -$11K-116.3% | $67K-71.4% | $236K+1322.0% | $17K-90.8% | $180K-92.8% | $2.5M-24.4% | $3.3M-1.5% | $3.3M-73.5% | $12.6M+82.6% | $6.9M+95.9% | $3.5M |
| Net Income | -$22.3M | -$21.6M+10.0% | -$24.0M-16.1% | -$20.7M-13.2% | -$18.3M-70.7% | -$10.7M-61.2% | -$6.6M-44.8% | -$4.6M-4032.4% | $117K+102.0% | -$5.9M-11.4% | -$5.3M+28.1% | -$7.4M-41.3% | -$5.2M+92.4% | -$68.8M-644.3% | -$9.2M+71.2% | -$32.0M |
| EPS (Diluted) | — | -$0.25+16.7% | -$0.30-11.1% | -$0.27-3.8% | -$0.26-62.5% | -$0.16-45.5% | -$0.11-10.0% | -$0.10-233.3% | -$0.03+90.6% | -$0.32 | -$0.54 | -$0.35-34.6% | -$0.26 | -$5.95 | -$1.33+77.2% | -$5.84 |
Not reported in any period shown, so not listed: Income Tax.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
STXS Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $52.3M+11.8% | $46.7M+11.5% | $41.9M-21.5% | $53.4M-12.4% | $61.0M+10.0% | $55.5M+27.2% | $43.6M+135.4% | $18.5M+73.6% | $10.7M-49.1% | $21.0M+11.1% | $18.9M-20.9% | $23.9M-23.2% | $31.1M-3.4% | $32.2M-19.4% | $39.9M |
| Current Assets | $33.8M+28.0% | $26.4M-20.5% | $33.3M-23.1% | $43.2M-15.8% | $51.4M-2.5% | $52.7M+35.8% | $38.8M+116.1% | $18.0M+82.1% | $9.9M-49.1% | $19.4M+13.2% | $17.1M-19.2% | $21.2M-23.4% | $27.7M-0.9% | $27.9M-18.4% | $34.2M |
| Cash & Equivalents | $13.4M+9.9% | $12.2M-38.4% | $19.8M+130.8% | $8.6M-77.8% | $38.7M-11.8% | $43.9M+45.6% | $30.2M+179.6% | $10.8M+192.9% | $3.7M-56.6% | $8.5M+52.0% | $5.6M-23.1% | $7.3M-47.2% | $13.8M+77.1% | $7.8M-44.3% | $14.0M |
| Inventory | $9.6M+14.8% | $8.3M-1.1% | $8.4M+7.0% | $7.9M+77.7% | $4.4M+34.5% | $3.3M+78.4% | $1.8M+55.0% | $1.2M+3.9% | $1.1M-78.7% | $5.4M+19.5% | $4.5M-29.3% | $6.4M+30.6% | $4.9M-4.3% | $5.1M-15.5% | $6.0M |
| Accounts Receivable | $5.8M+52.9% | $3.8M+0.1% | $3.8M-24.9% | $5.1M-5.8% | $5.4M+53.8% | $3.5M-34.0% | $5.3M+6.1% | $5.0M+17.1% | $4.3M-8.1% | $4.7M-26.8% | $6.4M-1.6% | $6.5M-14.3% | $7.6M-34.7% | $11.6M+4.2% | $11.1M |
| Goodwill | $3.8M0.0% | $3.8M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $33.5M-5.0% | $35.3M+76.6% | $20.0M-7.0% | $21.5M-0.4% | $21.6M+41.6% | $15.2M+1.1% | $15.1M-12.5% | $17.2M-53.8% | $37.2M-12.3% | $42.5M+16.3% | $36.5M+0.2% | $36.4M-14.8% | $42.8M-16.0% | $51.0M-13.3% | $58.8M |
| Current Liabilities | $22.4M+3.5% | $21.6M+63.1% | $13.2M-7.3% | $14.3M+7.8% | $13.3M-2.3% | $13.6M+11.6% | $12.2M+19.3% | $10.2M-66.2% | $30.1M-15.5% | $35.7M+120.9% | $16.1M-1.6% | $16.4M-31.1% | $23.8M-29.3% | $33.7M-17.6% | $40.8M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | $973K | N/A | N/A | N/A | N/A | $18.1M-1.7% | $18.4M-0.5% | $18.5M+9.8% | $16.8M-2.7% | $17.3M |
| Total Equity | $13.5M+121.7% | $6.1M-62.8% | $16.3M-38.0% | $26.3M-22.1% | $33.8M-2.3% | $34.6M+52.1% | $22.8M+1636.4% | $1.3M+104.9% | -$26.6M-23.6% | -$21.5M-21.9% | -$17.6M-40.4% | -$12.5M-7.2% | -$11.7M+37.7% | -$18.8M+0.2% | -$18.8M |
| Retained Earnings | -$583.4M-3.9% | -$561.7M-4.5% | -$537.7M-4.0% | -$517.0M-3.7% | -$498.7M-2.2% | -$488.0M-1.4% | -$481.3M-1.0% | -$476.7M+0.1% | -$477.1M-1.2% | -$471.2M-1.1% | -$466.0M-1.6% | -$458.6M-1.1% | -$453.4M-17.9% | -$384.6M-2.5% | -$375.4M |
STXS Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$15.3M | -$13.7M-61.1% | -$8.5M+7.0% | -$9.1M-8.6% | -$8.4M-185.6% | -$2.9M+16.1% | -$3.5M+23.9% | -$4.6M-81.3% | -$2.5M+45.5% | -$4.7M+28.8% | -$6.6M-159.6% | -$2.5M+72.2% | -$9.1M-43.6% | -$6.3M+47.7% | -$12.1M+61.6% | -$31.6M |
| Capital Expenditures | $213K | $93K+173.5% | $34K-90.7% | $366K-84.6% | $2.4M+70.2% | $1.4M+1870.5% | $71K+140.4% | $29K-88.9% | $265K+225.4% | $82K-80.1% | $410K | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | -$15.5M | -$13.8M-61.5% | -$8.5M+10.2% | -$9.5M+11.9% | -$10.8M-148.5% | -$4.3M-21.2% | -$3.6M+22.9% | -$4.6M-65.2% | -$2.8M+40.9% | -$4.8M+31.8% | -$7.0M | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | -$1.3M | -$93K-225.7% | $74K-99.6% | $19.8M+189.5% | -$22.1M-1481.5% | -$1.4M-1870.5% | -$71K-140.4% | -$29K+88.9% | -$265K-225.4% | -$82K | N/A | N/A | N/A | N/A | -$131K+87.3% | -$1.0M |
| Financing Cash Flow | $20.1M | $14.8M+4870.7% | $297K+266.7% | $81K-63.2% | $220K-59.8% | $547K-96.8% | $17.3M-27.8% | $24.0M+142.2% | $9.9M+16932.1% | -$59K | N/A | N/A | N/A | N/A | $6.1M-46.3% | $11.3M |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | N/A | N/A | $0 | $0 | $0 | $0 | $0 | N/A | N/A |
Not reported in any period shown, so not listed: Share Buybacks.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
STXS Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 52.7%-1.5pp | 54.2%-1.3pp | 55.5%-10.1pp | 65.6%-0.7pp | 66.3%-4.9pp | 71.2%-7.5pp | 78.8%-1.8pp | 80.5%+15.1pp | 65.5%-11.1pp | 76.6%+4.3pp | 72.3%-4.2pp | 76.5%+5.4pp | 71.1%+2.8pp | 68.3%-2.0pp | 70.2% |
| Operating Margin | -68.3%+23.6pp | -91.9%-10.3pp | -81.6%-14.9pp | -66.7%-29.9pp | -36.8%-11.6pp | -25.2%-8.5pp | -16.7%-8.3pp | -8.4%+10.6pp | -19.0%+1.0pp | -20.0%-5.6pp | -14.4%+1.0pp | -15.4%+7.9pp | -23.3%-0.4pp | -22.8%+53.3pp | -76.1% |
| Net Margin | -66.8%+22.5pp | -89.3%-12.0pp | -77.4%-12.4pp | -65.0%-34.4pp | -30.6%-5.6pp | -25.0%-9.1pp | -15.9%-16.3pp | 0.4%+19.3pp | -18.9%-2.5pp | -16.4%+3.1pp | -19.5%-4.7pp | -14.9% | -180.8% | -19.8%+56.5pp | -76.3% |
| Return on Equity | -160.5%+234.9pp | -395.5%-268.7pp | -126.7%-57.3pp | -69.4%-37.8pp | -31.7%-12.5pp | -19.2%+1.0pp | -20.2%-29.1pp | 8.9% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -41.4%+10.0pp | -51.5%-2.0pp | -49.4%-15.2pp | -34.3%-16.7pp | -17.6%-5.6pp | -12.0%-1.5pp | -10.5%-11.2pp | 0.6%+55.8pp | -55.2%-30.0pp | -25.2%+13.7pp | -39.0%-17.2pp | -21.8%+199.5pp | -221.3%-192.5pp | -28.7%+51.5pp | -80.2% |
| Current Ratio | 1.51+0.3x | 1.22-1.3x | 2.51-0.5x | 3.03-0.8x | 3.870.0x | 3.88+0.7x | 3.19+1.4x | 1.76+1.4x | 0.33-0.2x | 0.54-0.5x | 1.06-0.2x | 1.29+0.1x | 1.16+0.3x | 0.830.0x | 0.84 |
| Debt-to-Equity | 2.49-3.3x | 5.80+4.6x | 1.22+0.4x | 0.82+0.2x | 0.64+0.6x | 0.03-0.6x | 0.66-12.5x | 13.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| FCF Margin | -42.5%-10.9pp | -31.7%+3.8pp | -35.5%+2.9pp | -38.4%-25.9pp | -12.4%+1.1pp | -13.5%+2.6pp | -16.1%-6.5pp | -9.6%+5.7pp | -15.3%+6.4pp | -21.7% | N/A | N/A | N/A | N/A | N/A |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Similar Companies
Where Stereotaxis Ord Ranks
Frequently Asked Questions
What is Stereotaxis Ord's annual revenue?
Stereotaxis Ord (STXS) reported $32.4M in total revenue for fiscal year 2025. This represents a 20.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Stereotaxis Ord's revenue growing?
Stereotaxis Ord (STXS) revenue grew by 20.3% year-over-year, from $26.9M to $32.4M in fiscal year 2025.
Is Stereotaxis Ord profitable?
No, Stereotaxis Ord (STXS) reported a net income of -$21.6M in fiscal year 2025, with a net profit margin of -66.8%.
What is Stereotaxis Ord's EBITDA?
Stereotaxis Ord (STXS) had EBITDA of -$20.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Stereotaxis Ord's gross margin?
Stereotaxis Ord (STXS) had a gross margin of 52.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Stereotaxis Ord's operating margin?
Stereotaxis Ord (STXS) had an operating margin of -68.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Stereotaxis Ord's net profit margin?
Stereotaxis Ord (STXS) had a net profit margin of -66.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Stereotaxis Ord's return on equity (ROE)?
Stereotaxis Ord (STXS) has a return on equity of -160.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Stereotaxis Ord's free cash flow?
Stereotaxis Ord (STXS) recorded an outflow of $13.8M in free cash flow during fiscal year 2025. This represents a -61.5% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Stereotaxis Ord's operating cash flow?
Stereotaxis Ord (STXS) recorded an outflow of $13.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Stereotaxis Ord's total assets?
Stereotaxis Ord (STXS) had $52.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Stereotaxis Ord's capital expenditures?
Stereotaxis Ord (STXS) invested $93K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Stereotaxis Ord spend on research and development?
Stereotaxis Ord (STXS) invested $9.4M in research and development during fiscal year 2025.
What is Stereotaxis Ord's current ratio?
Stereotaxis Ord (STXS) had a current ratio of 1.51 as of fiscal year 2025, which is generally considered healthy.
What is Stereotaxis Ord's debt-to-equity ratio?
Stereotaxis Ord (STXS) had a debt-to-equity ratio of 2.49 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Stereotaxis Ord's return on assets (ROA)?
Stereotaxis Ord (STXS) had a return on assets of -41.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Stereotaxis Ord's cash runway?
Based on fiscal year 2025 data, Stereotaxis Ord (STXS) had $13.4M in cash against an annual operating cash burn of $13.7M. This gives an estimated cash runway of approximately 12 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Stereotaxis Ord's Altman Z-Score?
Stereotaxis Ord (STXS) has an Altman Z-Score of -13.60, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Stereotaxis Ord's Piotroski F-Score?
Stereotaxis Ord (STXS) has a Piotroski F-Score of 4 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Stereotaxis Ord's earnings high quality?
Stereotaxis Ord (STXS) reported a net loss of $21.6M while operations used $13.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Stereotaxis Ord cover its interest payments?
Stereotaxis Ord (STXS) reported an operating loss of $22.1M against $500K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Stereotaxis Ord?
Stereotaxis Ord (STXS) scores 39 out of 100 on our Financial Health Score, indicating weak standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.